Darya-Varia Laboratoria Tbk (DVLA.JK) Financials
DVLA.JK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 2.0 trillion | 594.4 billion |
2023-06-30 | 2.1 trillion | 602.1 billion |
2023-03-31 | 2.1 trillion | 595.7 billion |
2022-12-31 | 2.0 trillion | 605.5 billion |
DVLA.JK Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 110.4 billion | ? |
2023-06-30 | 7.1 billion | ? |
2023-03-31 | -50.6 billion | ? |
2022-12-31 | 21.5 billion | ? |
DVLA.JK Net Income
Date | Net Income |
---|---|
2023-09-30 | 3.5 billion |
2023-06-30 | 35.4 billion |
2023-03-31 | 60.9 billion |
2022-12-31 | -15.9 billion |
DVLA.JK Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 341.0 billion | 1.2 billion | 1.6 billion |
2023-06-30 | 316.7 billion | 1.3 billion | 1.7 billion |
2023-03-31 | 307.7 billion | 1.4 billion | 1.8 billion |
2022-12-31 | 357.0 billion | 1.5 billion | 1.9 billion |
DVLA.JK Shares Outstanding
DVLA.JK Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 59.3 billion | 8.0 billion | 171.5 billion | - |
2023-06-30 | 37.7 billion | - | 184.4 billion | - |
2023-03-31 | 26.4 billion | - | 168.6 billion | - |
2022-12-31 | 14.4 billion | 3.2 billion | 188.9 billion | - |
DVLA.JK Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 367.1 billion | 186.9 billion |
2023-06-30 | 469.3 billion | 222.5 billion |
2023-03-31 | 513.2 billion | 251.8 billion |
2022-12-31 | 389.7 billion | 197.4 billion |
DVLA.JK
Price: IDR1,510
Dividend Yield: 0.08%
Forward Dividend Yield: 11.32%
Payout Ratio: 232.59%
Dividend Per Share: 172.00 IDR
Earnings Per Share: 73.95 IDR
P/E Ratio: 22.32
Exchange: JKT
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.7 trillion
Average Dividend Frequency: 2
Years Paying Dividends: 16
DGR3: 26.60%
DGR5: 15.96%
DGR10: 30.00%